Trial intelligence / Profile preview

BOTOX for sub-acute low back pain in military personnel

NCT00384371Phase 4Terminated

Sponsor
United States Department of Defense
Start
Jun 2008
Primary completion
Sep 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in low back pain (LBP), sponsored by United States Department of Defense. Started Jun 2008; status: terminated.

02

Drugs

botulinum toxin type A
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT00384371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00384371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call